Use of selective antagonists to dissociate the central cardiovascular and behavioral effects of tachykinins on NK1 and NK2 receptors in the rat
Carsten Tschöpe(Deutsches Herzzentrum der Charité), Th. Unger, Réjean Couture(Université de Montréal), Juraj Čulman(University Hospital Schleswig-Holstein), A. Pratl, D. Regoli(University of Ferrara), Pierre Picard(Université de Montréal)
Cited by 4
Related Papers
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
|Pharmacological Reviews|2000|2.1k
Type 2 Diabetes Mellitus and Heart Failure: A Position Statement from the Heart Failure Association of the European Society of Cardiology
|European Journal of Heart Failure|2018|716
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Kinin receptors in pain and inflammation
|European Journal of Pharmacology|2001|465
Inflammation – Cause or Consequence of Heart Failure or Both?
|Current Heart Failure Reports|2017|457